Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-05
1997-06-03
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514250, 514271, 514866, A61K 3144, A61K 31515, A61K 3150
Patent
active
056355122
ABSTRACT:
A process for the long term modification and regulation of linid and glucose metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or hyperglycemia, or both (these being the hallmarks of noninsulin dependent, or Type II diabetes)--by administration to a vertebrate, animal or human, of a dopamine agonist and a prolactin stimulator. The dopamine agonist and prolactin stimulator are administered in daily dosages, respectively, at a time of day dependent on the normal circadian rhythm of fat and lean members of a similar species. Decreases in body fat deposits result by treatment of an obese species on a daily timed sequence based on circadian rhythms of the peak prolactin, or peak prolactin and peak glucocorticosteroid, blood level established for lean insulin sensitive members of a similar species. The dopamine agonist is administered at the time of, or just after the time of peak plasma prolactin concentration found in lean animals of the same species and the prolactin stimulator is administered at a time just before the plasma prolactin rhythm reaches its peak in lean animals. Insulin resistance, and hyperinsulinemia or hyperglycemia, or both, can also be controlled in humans on a long term basis by treatment corresponding to that of the treatment for obesity. The short term daily injections reset hormonal timing in the neural centers of the brain to produce long term effects.
REFERENCES:
patent: 3074847 (1963-01-01), Bigsby et al.
patent: 4239763 (1980-12-01), Milvec et al.
patent: 4659715 (1987-04-01), Meier et al.
patent: 4749709 (1988-06-01), Meier et al.
patent: 4783469 (1988-11-01), Meier et al.
patent: 5006526 (1991-04-01), Meier et al.
patent: 5344832 (1994-09-01), Cincotta et al.
patent: 5468755 (1995-11-01), Cincotta et al.
Cassar, J. et al. "Bromocriptine Treatment of Acromegaly," Metabolism 26: 539-546 (1977).
Dolocek, R. et al. "Bromocriptine and glucose tolerance in acromegalics," Pharmatherapeutica 3: 100-106 (1982).
Eskildsen, P.C. et al. "Long-Term Treatment of Acromegaly with Bromocriptine," Acta Endocr. 87: 687-700 (1978).
Steinbeck, K. and J.R. Turtle, "Treatment of Acromegalywith Bromocryptine," Aust. N.Z. J. Med. 9: 217-224 (1979).
Wass, J.A.H. et al. "An Assessment of Glucose Intolerance In Acromegaly and Its Response to Medical Treatment," Clin. Endocr. 12: 53-59 (1980).
Harel et al., Proc. La. Acad. of Sci., 38:125, 1975.
Joseph et al., Proc. Soc. Exp. Biol. Med., 146:1150-1155, 1974.
Komorowski et al., Aliment. Nutr. Metab., 1(4):293, 1980.
Larsson et al., Lakartidiningen (Sweden), 82(50):4425, 1985.
Martin et al., The Condor, 75:369-374, 1973.
Martin et al., "Hormonal Control of Orientation in the White-Throated Sparrow, Zonatrichia Albicollis." Chronobiology, pp. 641-646, 1974.
Martin et al., Proc. La Acad. of Sci., 38:127, 1975.
Martin et al., Am. Zoologist, 18(3):572, 1978.
Martin, D., "Hormonal Regulation of Migratory Orientation in the White-Throated Sparrow, Zonatrichia Albicollis." Diss. LSU, 1974.
Martin, D., "Factors Influencing the Circadian Rhythm of Locomotor Activity in the Anabatoid Fish, Trichogster Trichopterus Sumatranus." Thesis. Sam Houston State College, 1969.
Meier et al., Experientia, 48:248-253, 1992.
Meier et al., Physiol. Zool., 41(1):95-103, 1968.
Southern et al., J. Anim. Sci., 68:931-936, 1990.
Wilson, Chrono. Bio. Int. 6:113-121, 1989.
Cincotta et al. Life Sciences 45:2247-2254, 1989.
Cincotta et al. Ann Nutr Metab 33:305-314, 1989.
Cincotta et al. Horm Metabol. Res 21:64-68, 1989.
Cincotta et al., J. Endocrinol. 120:385-391, 1989.
Moore et al., Biology of Reproduction 36:47-58, 1987.
Cincotta et al., Experientia 43:416-417, 1987.
Bartness et al., J. Exp. Zoology 244:437-454, 1987.
Emata et al., J. Exp. Zoology 233:29-34, 1985.
Lobato et al. Mol. and Cell. Biochem. 67:19-23, 1985.
Cincotta et al. J. Endocrinol. 106:177-181, 1985.
Cincotta et al. J. Endocrinol. 106:173-176, 1985.
Meier et al., Transactions of the American Fisheries Society 113:433-431, 1984.
Eisemann et al., J. of Animal Sci. 59(1)95-104, 1984.
Eisemann et al., J. of Animal Sci. 59(1)86-94, 1984.
Meier et al., Current Ornithology 2:303-343, 1984.
Cincotta, J. Endocrinol. 103:141-146, 1984.
Miller et al., J. Interdiscipl. Cycle Res. 14(1):75-84, 1983.
Miller et al., J. Interdiscipl. Cycle Res. 14(2):85-94, 1982.
Ottenweller et al., Life Sciences 28:1033-1040, 1980.
Barnett, Post Graduate Medical J. 56:11-14, 1980.
Horseman et al., General and Comparative Endocrinology 38:269-274, 1979.
Horseman et al., J. Endocr. 82:367-372, 1979.
Meier et al., Circadian hormone basis for seasonal conditions in the gulf killifish Fundulus grandis. In Comparative Endocrinology, pp. 141-144. Galliard et al. (eds), Elsevier/North Holland Biomedical Press, Amsterdam (1978).
Spieler et al., Life Sciences 22:255-258, 1977.
Meier et al., Amer. J. of Physiology 232(2):E193-E196, 1977.
Meier et al., Amer. Zool. 16:649-659, 1976.
Meier et al., General and Comparative Endocrinology 26:253-258, 1975.
Meier, Amer. Scientist 61(2)184-187, 1973.
Berle, Acta endocr. Suppl. 173, Abstract No. 104, 1973.
Meier et al., Biology of Reproduction 8:400-410, 1973.
Meier et al., General and Comparative Endocinology Suppl. 3:499-508, 1972.
Meier et al., Proc. Soc. for Exp. Bio. & Med. 137:408-415, 1971.
Meier et al., Gen. & Comp. Endocrin. 17:311-318, 1971.
Joseph et al., J. Exp. Zool. 178(1):59-62, 1971.
Meier et al., Science 173:1240-42, 1971.
Meier et al., Proc. Soc. Exp. Biol. and Med. 133(4):1113-16, 1970.
Lee et al., J. of Exp. Zool. 166(3):307-316, 1967.
Meier et al., Gen. & Comp. Endocrin. 8(1):110-114, 1967.
(1989) Acta. Diabetol. Lat., vol. No. 26(2), pp. 133-145.
(1982) Chemical Abstracts, vol. No. 96, No. 11, Abstract No. 80405f.
(1990) Chemical Abstracts, vol. No. 112, No. 21, Abstract No. 191532p.
(1984) Chemical Abstracts, vol. No. 101, No. 7, Abstract No. 49205p.
(1982) Chemical Abstracts, vol. No. 97, No. 19, Abstracts No. 156398a.
(1982) Chemical Abstracts, vol. No. 97, No. 3, Abstract No. 17600w.
(1981) Chemical Abstracts, vol. No. 95, No. 1, Abstract No. 530j.
(1980) Chemical Abstracts, vol. No. 93, No. 13, Abstract No. 125921c.
(1979) Chemical Abstracts, vol. No. 91, No. 5, Abstract No. 36590k.
Cincotta Anthony H.
Meier Albert H.
Board of Supervisors of Louisiana Business and Agricultural and
Ergo Science Incorporated
Weddington Kevin E.
LandOfFree
Method for modifying or resetting the prolactin rhythm of an ins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for modifying or resetting the prolactin rhythm of an ins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for modifying or resetting the prolactin rhythm of an ins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-391926